|Day's Range||315.51 - 316.48|
|52 Week Range||203.63 - 316.80|
|PE Ratio (TTM)||40.22|
|Dividend & Yield||1.04 (0.33%)|
|1y Target Est||N/A|
Medical device maker AngioDynamics filed a lawsuit alleging its competitor, C.R. Bard, is violating antitrust laws with the sale of its catheters. AngioDynamics (ANGO) claims in the lawsuit C.R. Bard (BCR:NYSE) is illegally tying its catheter tip location systems to its own line of catheters, preventing customers from using other catheters from other companies.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to C.R. Bard, Inc. (New Jersey) Here are 5 ETFs with the largest exposure to BCR-US. Comparing the performance and risk of C.R. Bard, Inc. (New Jersey) with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)
C.R. Bard (BCR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.